Why is the demand for preventive cancer vaccines growing?

The preventive vaccine segment in the market is expected to generate USD 15.5 billion by 2032 as preventing cancer through vaccination reduces the need for costly treatments.

How big is the U.S. cancer vaccine industry?

U.S. cancer vaccine market is projected to reach USD 8.5 billion by 2032 owing to the increasing prevalence of cancer in the country

Mention the key players involved in cancer vaccine industry?

Ayala Pharmaceuticals, AstraZeneca PLC, Amgen Inc., Bristol-Myers, Squibb Company, Dynavax Technologies Corporation, Dendreon Pharmaceuticals LLC, Ferring Pharmaceuticals, and F. Hoffmann-La Roche Ltd among others.

Cancer Vaccine Market Size

Report ID: GMI10285

Published Date: July 2024

Report Format: PDF

Download Free PDF

Cancer Vaccine Market Size

Cancer Vaccine Market size was valued at around USD 9.1 billion in 2023 and is estimated to grow at 11.2% CAGR from 2024 to 2032. Cancer vaccines are immunotherapies designed to stimulate the immune system to recognize and attack cancer cells, either by preventing cancer (prophylactic) or treating existing cancers (therapeutic). Preventive vaccines, such as those for HPV and Hepatitis B, aim to prevent cancers caused by these viruses, while therapeutic vaccines, such as sipuleucel-T for prostate cancer, target cancer-specific antigens to elicit an immune response.

The rising prevalence of cancer is a significant driving factors for the market. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. This underscores the critical need for innovative treatments and preventive measures, highlighting the pivotal role of cancer vaccines in potentially reducing cancer incidence and mortality.

Furthermore, advancements in biotechnology and immunotherapy, growing demand for personalized medicine, and rising geriatric population, are the promoting factors advancing the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Question(FAQ) :

What is the size of the cancer vaccine industry?: Cancer vaccine market size was valued at USD 9.1 billion in 2023 and is estimated to grow at 11.2% CAGR from 2024 to 2032 driven by the rising prevalence of cancer.
Why is the demand for preventive cancer vaccines growing?: The preventive vaccine segment in the market is expected to generate USD 15.5 billion by 2032 as preventing cancer through vaccination reduces the need for costly treatments.
How big is the U.S. cancer vaccine industry?: U.S. cancer vaccine market is projected to reach USD 8.5 billion by 2032 owing to the increasing prevalence of cancer in the country
Mention the key players involved in cancer vaccine industry?: Ayala Pharmaceuticals, AstraZeneca PLC, Amgen Inc., Bristol-Myers, Squibb Company, Dynavax Technologies Corporation, Dendreon Pharmaceuticals LLC, Ferring Pharmaceuticals, and F. Hoffmann-La Roche Ltd among others.

Related Reports

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2023

Companies covered: 15

Tables & Figures: 288

Countries covered: 23

Pages: 195

Download Free PDF

Cancer Vaccine Market Size

Cancer Vaccine Market Size

Premium Report Details

Industries

Information

Link

Global Headquarters